CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Switch to insulin therapy does not reduce rate of UTIs in Type 2 diabetics


11 March 2010

MedWire News: There is no evidence that switching from oral treatment to insulin therapy reduces the high rate of urinary tract infections (UTIs) in patients with Type 2 diabetes, say researchers.

Type 2 diabetics have an increased risk for UTIs, particularly adult women who have a self-reported rate of about 10%.

“The biological mechanisms of increased UTI risk among diabetic patients remain uncertain, but are likely to include immune mechanisms responsive to the quality of glycemic control,” say Reimar Thomsen (Aarhus University Hospital, Aalborg, Denmark) and colleagues.

It has been suggested that insulin treatment may have a protective effect against UTIs, as it is thought to have anti-inflammatory properties and protect against infection. Thomsen and team therefore investigated the risk for antibiotic-treated UTIs in 2737 Type 2 diabetics before and after they switched from oral antidiabetic agents to insulin treatment.

The researchers observed each patient for 365 days before and after switching treatment, excluding a 120-day window around the switch date. UTI infections were defined as filled prescriptions for UTI-specific antibiotics.

Following the switch to insulin, 53% of patients had a significant decrease in glycated hemoglobin (median=1.5%). In the period before switching 437 (16.0%) patients had UTIs and after switching 446 (16.3%) patients had UTIs, demonstrating no significant difference in rates following change in treatment for diabetes.

“This population-based study showed a high annual risk of treated UTIs in Type 2 diabetic patients with no substantial effect of improved glycemic control and/or initiation of insulin therapy,” conclude Thomsen et al in the Journal of Diabetes and Its Complications.

They say: “The increased risk for UTI in diabetics is apparently not reduced by tightened glycemic control.

“However, this treatment goal should be retained to reduce classic complications of diabetes.”

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

J Diabetes Complications 2010; Advance online publication



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions